Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice

Ya Tin Lin, Ho Ling Liu, Yuan Ji Day, Che Chien Chang, Po Hung Hsu, Jin Chung Chen

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)


Neuropeptide FF (NPFF) is recognized as an opioid modulating peptide that regulates morphine-induced analgesia. The aim of this study was to delineate the role of NPFFR2 in pain transmission. We found the expression levels of NPFF and NPFFR2 were increased in the lumbar dorsal horn of animals with CFA- and carrageenan-induced inflammation and both NPFFR2 over-expressing transgenic (NPFFR2-Tg) and NPFFR2 agonist-treated mice displayed hyperalgesia. BOLD signals from functional MRI showed that NPFFR2-Tg mice exhibited increased activation of pain-related brain regions after painful stimulation when compared to WT mice. Inflammatory mediators within the spinal cord, calcitonin gene-related peptide (CGRP) and substance P (SP), were up-regulated in NPFFR2-Tg and chronic NPFFR2 agonist-treated mice. In DRG cultures, treatment with an NPFFR2 agonist induced the expression and release of CGRP, an action which was blocked by NPFFR2 siRNA. Furthermore, treatment with a CGRP antagonist ameliorated the pain hyperalgesia in NPFFR2-Tg mice, returning the pain threshold to a control level. However, treatment with a SP antagonist reduced the pain responses in both WT and NPFFR2-Tg mice and did not suppress pain hypersensitivity in NPFFR2-Tg mice. Together, these results demonstrate that NPFFR2 activation modulates pain transmission by up-regulating the pain mediator CGRP, leading to hyperalgesia.
頁(從 - 到)62-73
期刊Experimental Neurology
出版狀態已發佈 - 5月 2017

ASJC Scopus subject areas

  • 神經內科
  • 發展神經科學


深入研究「Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice」主題。共同形成了獨特的指紋。